是

我们是谁

  • 4 月 5, 2022
    Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer
  • 4 月 5, 2022
    A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
  • 4 月 5, 2022
    Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer
  • 4 月 5, 2022
    Local Immunomodulation After Radiofrequency of Unresectable Colorectal Liver Metastases
  • 4 月 5, 2022
    Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)
  • 4 月 5, 2022
    A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors
  • 4 月 5, 2022
    Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers
  • 4 月 5, 2022
    Adoptive Cell Therapy Across Cancer Diagnoses
  • 4 月 5, 2022
    Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
  • 4 月 5, 2022
    Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer